Further studies are needed to examine if levels of ID2 expression are prognostic for AML patient subsets, and to determine if ID2 is expressed in LSCs and functions to regulate their quiescence and survival (Figure 3). The gene discussed is ID2; the disease is acute myeloid leukemia.